BLUELINEA (ALBLU.PA) Fundamental Analysis & Valuation

EPA:ALBLU • FR0011041011

Current stock price

0.462 EUR
-0.03 (-5.71%)
Last:

This ALBLU.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALBLU.PA Profitability Analysis

1.1 Basic Checks

  • ALBLU had negative earnings in the past year.
  • ALBLU had a positive operating cash flow in the past year.
  • In the past 5 years ALBLU always reported negative net income.
  • ALBLU had negative operating cash flow in 4 of the past 5 years.
ALBLU.PA Yearly Net Income VS EBIT VS OCF VS FCFALBLU.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

  • With a Return On Assets value of -7.96%, ALBLU is not doing good in the industry: 69.35% of the companies in the same industry are doing better.
  • The Return On Equity of ALBLU (-106.93%) is worse than 80.65% of its industry peers.
Industry RankSector Rank
ROA -7.96%
ROE -106.93%
ROIC N/A
ROA(3y)-13.4%
ROA(5y)-23.48%
ROE(3y)-62.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBLU.PA Yearly ROA, ROE, ROICALBLU.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • With an excellent Gross Margin value of 98.54%, ALBLU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • ALBLU's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.37%
GM growth 5Y2.44%
ALBLU.PA Yearly Profit, Operating, Gross MarginsALBLU.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALBLU.PA Health Analysis

2.1 Basic Checks

  • ALBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALBLU has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALBLU has more shares outstanding
  • ALBLU has a worse debt/assets ratio than last year.
ALBLU.PA Yearly Shares OutstandingALBLU.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBLU.PA Yearly Total Debt VS Total AssetsALBLU.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -3.03, we must say that ALBLU is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ALBLU (-3.03) is worse than 83.87% of its industry peers.
  • A Debt/Equity ratio of 5.85 is on the high side and indicates that ALBLU has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 5.85, ALBLU is doing worse than 87.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.85
Debt/FCF N/A
Altman-Z -3.03
ROIC/WACCN/A
WACC6.87%
ALBLU.PA Yearly LT Debt VS Equity VS FCFALBLU.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 0.37 indicates that ALBLU may have some problems paying its short term obligations.
  • The Current ratio of ALBLU (0.37) is worse than 90.32% of its industry peers.
  • ALBLU has a Quick Ratio of 0.37. This is a bad value and indicates that ALBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.33, ALBLU is doing worse than 88.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.33
ALBLU.PA Yearly Current Assets VS Current LiabilitesALBLU.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ALBLU.PA Growth Analysis

3.1 Past

  • ALBLU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.35%, which is quite impressive.
  • Looking at the last year, ALBLU shows a small growth in Revenue. The Revenue has grown by 7.97% in the last year.
  • The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)58.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.22%
Revenue 1Y (TTM)7.97%
Revenue growth 3Y7.87%
Revenue growth 5Y8.42%
Sales Q2Q%17.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBLU.PA Yearly Revenue VS EstimatesALBLU.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBLU.PA Yearly EPS VS EstimatesALBLU.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALBLU.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALBLU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBLU.PA Price Earnings VS Forward Price EarningsALBLU.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALBLU is valued cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.96
ALBLU.PA Per share dataALBLU.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBLU.PA Dividend Analysis

5.1 Amount

  • ALBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBLU.PA Fundamentals: All Metrics, Ratios and Statistics

BLUELINEA

EPA:ALBLU (3/27/2026, 7:00:00 PM)

0.462

-0.03 (-5.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.51M
Revenue(TTM)10.26M
Net Income(TTM)-755.70K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.83
P/FCF N/A
P/OCF 24.66
P/B 12.04
P/tB N/A
EV/EBITDA 8.96
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.02
OCFY4.06%
SpS0.56
BVpS0.04
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.96%
ROE -106.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.54%
FCFM N/A
ROA(3y)-13.4%
ROA(5y)-23.48%
ROE(3y)-62.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.37%
GM growth 5Y2.44%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 5.85
Debt/FCF N/A
Debt/EBITDA 3.54
Cap/Depr 71.57%
Cap/Sales 12.95%
Interest Coverage N/A
Cash Conversion 29.57%
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.33
Altman-Z -3.03
F-Score5
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)146.58%
Cap/Depr(5y)113.61%
Cap/Sales(3y)22.56%
Cap/Sales(5y)17.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.97%
Revenue growth 3Y7.87%
Revenue growth 5Y8.42%
Sales Q2Q%17.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.83%
OCF growth 3YN/A
OCF growth 5YN/A

BLUELINEA / ALBLU.PA Fundamental Analysis FAQ

What is the fundamental rating for ALBLU stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALBLU.PA.


What is the valuation status of BLUELINEA (ALBLU.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to BLUELINEA (ALBLU.PA). This can be considered as Overvalued.


How profitable is BLUELINEA (ALBLU.PA) stock?

BLUELINEA (ALBLU.PA) has a profitability rating of 2 / 10.